The Doctors Company Announces New Tribute Plan Milestone: $175 Million Distributed to Members
NAPA, Calif., May 30, 2024 /PRNewswire/ — The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has now distributed more than $175 million in Tribute® Plan awards to almost 14,000 members. Founded in 2007, the
Pasternack’s New RF Fixed Attenuators and Terminations Feature NEX10 Connectorized Design
New Product Line Operates at Up to 6 GHz, Offers Compactness and Performance IRVINE, Calif., May 30, 2024 /PRNewswire/ — Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave and millimeter-wave products, has announced its new RF fixed attenuators and terminations w
SoCalGas Declares Preferred Dividends
LOS ANGELES, May 30, 2024 /PRNewswire/ — The board of directors of Southern California Gas Company (SoCalGas) has declared regular quarterly dividends for the preferred series stock of the company as follows: SoCalGas: Preferred Stock $0.375 per share Preferred Stock, Series A $0.375 per shar
Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy
STOCKHOLM, May 30, 2024 /PRNewswire/ — Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”), today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending t
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted by AkesoPFS Improvement Was Observed Broadly in Patients Across Subgroups, including PD-L1 Low and PD-L1 High Expressing Tumors, Squamous and Non-Squamous HistologiesFull Data Set to be Presented at an Up
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or
BMO Celebrates Pride with Return of Rainbow Deposits
For the third consecutive year, BMO Rainbow Deposits campaign invites people to spot, snap and deposit rainbows at BMORainbowDeposits.com TORONTO and CHICAGO, May 30, 2024 /PRNewswire/ – BMO is kicking off the third year of its Pride-themed “Rainbow Deposits” campaign, running to
Beyond Bollywood: NYIFF 2024 Explores the Rich Tapestry of Indian Cinema
NYIFF 2024 delves into the multifaceted realm of Indian cinema and celebrates the illustrious legacy of Shabana Azmi with a retrospective tribute. NEW YORK, May 30, 2024 /PRNewswire/ — The New York Indian Film Festival (NYIFF), North America’s longest-running festival dedicated to India
The ALS Association Teams Up with MLB Pitcher Aaron Nola to #StrikeOutALS, Celebrate 4th Annual Lou Gehrig Day
Philadelphia Phillies Pitcher Continues Support of Fight Against ALS in Honor of Late Uncle ARLINGTON, Va., May 30, 2024 /PRNewswire/ — The ALS Association is excited to celebrate the 4th annual Lou Gehrig Day, taking place on June 2nd at baseball parks across the country. Lou Gehrig Day hono
Omega Healthcare Presents Real-World Data Curation Model Helping to Advance Oncology Research
Sessions outline a new hybrid operational model used by Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute to curate structured real-world data for oncology research. BOCA RATON, Fla., May 30, 2024 /PRNewswire/ — Omega Healthcare released the details of poster sessions c
